Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 3, 2017
Clinical News

RG-101 regulatory update

BioCentury | Aug 15, 2016
Clinical News

RG-101 regulatory update

BioCentury | Jul 18, 2016
Clinical News

RG-101: Additional Phase II data

BioCentury | Jul 11, 2016
Clinical News

RG-101: FDA hold

BioCentury | Jun 29, 2016
Company News

Regulus shares fall after clinical hold news

BioCentury | Jun 28, 2016
Top Story

Regulus sinks on clinical hold

BioCentury | Jun 6, 2016
Company News

GlaxoSmithKline, Regulus deal

BioCentury | Apr 25, 2016
Clinical News

RG-101: Additional Phase II data

BioCentury | Apr 16, 2016
Clinical News

Regulus slips after latest round of HCV data

BioCentury | Feb 22, 2016
Clinical News

RG-101: Interim Phase II data

Items per page:
1 - 10 of 29